| 1 | Cancer | 3.31% | |
| 2 | Patients | 2.21% | |
| 3 | Study | 1.66% | |
| 4 | ASCO | 1.66% | |
| 5 | Identify | 1.1% | |
| 6 | Risk | 1.1% | |
| 7 | Its | 1.1% | |
| 8 | Receptor | 1.1% | |
| 9 | Dormant | 1.1% | |
| 10 | Could | 1.1% | |
| 11 | Therapy | 1.1% | |
| 12 | New | 1.1% | |
| 13 | Chief | 1.1% | |
| 14 | Show | 1.1% | |
| 15 | Says | 1.1% | |
| 16 | Prostate | 1.1% | |
| 17 | Scientific | 1.1% | |
| 18 | Use | 1.1% | |
| 19 | Against | 1.1% | |
| 20 | Satellos | 1.1% | |
| 21 | Found | 1.1% | |
| 22 | Cells | 1.1% | |
| 23 | Effectiveness | 0.55% | |
| 24 | Eliminate | 0.55% | |
| 25 | Smell | 0.55% | |
| 26 | Day | 0.55% | |
| 27 | Boost | 0.55% | |
| 28 | Higher | 0.55% | |
| 29 | Drugs | 0.55% | |
| 30 | (ARPI) | 0.55% | |
| 31 | Servings | 0.55% | |
| 32 | Fight | 0.55% | |
| 33 | Pathogens | 0.55% | |
| 34 | Berries | 0.55% | |
| 35 | (MMAI) | 0.55% | |
| 36 | Utility | 0.55% | |
| 37 | Muscle | 0.55% | |
| 38 | Non-Metastatic | 0.55% | |
| 39 | Multimodal | 0.55% | |
| 40 | Syndrome | 0.55% | |
| 41 | Invasive | 0.55% | |
| 42 | Trials | 0.55% | |
| 43 | AMR | 0.55% | |
| 44 | Improvement | 0.55% | |
| 45 | Mutation | 0.55% | |
| 46 | Hypercoagulopathy | 0.55% | |
| 47 | 2nd-Generation | 0.55% | |
| 48 | After | 0.55% | |
| 49 | GIP | 0.55% | |
| 50 | Pathways | 0.55% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||